Oyster Point Pharma (NASDAQ:OYST) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS

Oyster Point Pharma (NASDAQ:OYST – Get Rating) posted its quarterly earnings data on Thursday. The company reported ($1.80) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.75) by ($0.05), Fidelity Earnings reports. During the same period last year, the business posted ($0.73) earnings per share. NASDAQ:OYST traded down $0.46 during mid-day […]

Related Keywords

United States , ,Oyster Point Pharma Inc ,Morgan Stanley ,Goldman Sachs Group Inc ,Zacks Investment Research ,Blackrock Inc ,Nasdaq ,Citadel Advisors ,Millennium Management ,Oyster Point Pharma ,Get Rating ,Fidelity Earnings ,Point Pharma ,Sachs Group ,Nasdaq Oyst ,Boyst ,Medical ,Earnings ,